GlobalData on MSN3d
Takeda broadens its deal with BridGene for up to $770m
Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology. Takeda will pay ...
FierceBiotech4d
Takeda fronts $46M for 2nd small molecule collab with BridGene
Takeda has returned to BridGene Biosciences for another small-molecule collaboration—this time focused on immunology as well ...
Contract Pharma3d
BridGene Biosciences, Takeda Partner to Discover Small Molecule Drugs
BridGene Biosciences Inc. has entered a strategic collaboration and licensing agreement with Takeda through which it will use ...
The Pharma Letter3d
BridGene Biosciences and Takeda expand their collaboration
Privately-held BridGene Biosciences has announced a strategic collaboration and licensing agreement with Japan’s Takeda. The ...
BioSpace4d
Takeda Pumps $770M Into Another BridGene Pact to Hit ‘Undruggable’ Targets
BridGene strikes another partnership with Takeda as the latter company continues its dealmaking streak, following high-ticket agreements with Keros Therapeutics, AC Immune and Degron Therapeutics in ...
Morningstar4d
BridGene Biosciences Announces Strategic Collaboration with Takeda to Discover Small Molecule Drugs for Immunology and Neurology Targets
BridGene is also eligible to receive tiered royalties on net sales of any products that may result from the collaboration. "We are excited to continue our collaboration with Takeda in the ...